Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker

Pancreatic ductal adenocarcinoma (PDA) is the most frequent type of pancreatic cancer and one of the deadliest diseases overall. New biomarkers are urgently needed to allow early diagnosis, one of the only factors that currently improves prognosis. Here we analyzed whether the detection of circulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Bosch, Neus, Barranco, Luis E., Orozco, Carlos A., Moreno, Mireia, Visa, Laura, Iglesias, Mar, Oldfield, Lucy, Neoptolemos, John P., Greenhalf, William, Earl, Julie, Carrato, Alfredo, Costello, Eithne, Navarro, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152472/
https://www.ncbi.nlm.nih.gov/pubmed/30250644
http://dx.doi.org/10.18632/oncotarget.26034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152472/
https://www.ncbi.nlm.nih.gov/pubmed/30250644
http://dx.doi.org/10.18632/oncotarget.26034

Ejemplares similares